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Abstract
 
Reduced mechanical stress to bone in bedridden patients and astronauts leads to bone loss and
increase in fracture risk which is one of the major medical and health issues in modern aging
society and space medicine. However, no molecule involved in the mechanisms underlying
this phenomenon has been identified to date. Osteopontin (OPN) is one of the major noncol-
lagenous proteins in bone matrix, but its function in mediating physical-force effects on bone
in vivo has not been known. To investigate the possible requirement for OPN in the transduc-
tion of mechanical signaling in bone metabolism in vivo, we examined the effect of unloading
 
on the bones of OPN
 
2
 
/
 
2
 
 mice using a tail suspension model. In contrast to the tail suspension–
induced bone loss in wild-type mice, OPN
 
2
 
/
 
2
 
 mice did not lose bone. Elevation of urinary
deoxypyridinoline levels due to unloading was observed in wild-type but not in OPN
 
2
 
/
 
2
 
mice. Analysis of the mechanisms of OPN deficiency–dependent reduction in bone on the cel-
lular basis resulted in two unexpected findings. First, osteoclasts, which were increased by un-
loading in wild-type mice, were not increased by tail suspension in OPN
 
2
 
/
 
2
 
 mice. Second,
measures of osteoblastic bone formation, which were decreased in wild-type mice by unload-
ing, were not altered in OPN
 
2
 
/
 
2
 
 mice. These observations indicate that the presence of OPN
is a prerequisite for the activation of osteoclastic bone resorption and for the reduction in os-
teoblastic bone formation in unloaded mice. Thus, OPN is a molecule required for the bone
loss induced by mechanical stress that regulates the functions of osteoblasts and osteoclasts.
Key words: osteopontin • mechanical stress • osteoblasts • osteoclasts • tail suspension
 
Introduction
 
Bone is a highly dynamic tissue that has evolved over mil-
lions of years on earth under gravitational stress to provide
mechanical support for both locomotion and protection, to
serve as a calcium reservoir for mineral homeostasis, and to
support hemopoiesis (1). The structure, organization, and
remodeling of bone are sensitive to the mechanical envi-
ronment evidenced by the bone loss in bedridden patients
or space flight, as well as the increase in bone mass in ath-
letes participating in high impact sports (2). Especially in
the modern aging society, where the incidence of os-
teoporosis is soaring, bone loss due to reduced physical ac-
tivity in aged people is one of the major risk factors for this
disease. In contrast to the presence of these valid observa-
tions on the effects of physical force on bone metabolism,
no molecule has been identified to date to mediate the ef-
fects of physical force on bone in vivo.
Integrins mediate extracellular signals to the cells and are
involved in several physiological and pathological events (3,
4). Integrins have been suggested also to transduce signals
to the cells in response to mechanical stimuli (5–7). One of
the integrin ligands present in bone is osteopontin (OPN).
OPN is an arginine-glycine-aspartate–containing noncol-
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lagenous protein abundant in the bone matrix that is pro-
duced by osteoblasts and osteoclasts. It may facilitate osteo-
clast attachment to the mineralized extracellular matrix
during bone resorption (8–11). Although OPN does not
appear to be required for normal development of bones
(12–14), the absence of OPN makes the animal less sensi-
tive to ovariectomy-induced bone resorption (15).
OPN expression is regulated by calcitropic cytokines and
hormones as well as mechanical stress both in vitro and
in vivo. Intermittent hydrostatic compression, four point
bending, and experimental tooth movement enhance OPN
expression in osteoblasts or osteoclasts in vitro or in vivo
(16–20). Mechanical forces have been suggested to act at
the sites of cell attachment, possibly involving extracellular
matrix proteins including OPN, to generate a shear stress at
adhesion plaques, to transmit signals via integrins to the cy-
toskeleton, and to modify cell shape and gene expression
(21). These observations suggest that OPN is involved in
the alterations in bone metabolism induced by mechanical
stress; however, there is as yet no direct evidence for this
hypothesis either in vitro or in vivo.
The aim of the work reported here is to investigate the
role of OPN in bone loss induced by the reduction of me-
chanical stress by using OPN knockout mice subjected to
tail suspension.
 
Materials and Methods
 
Animals.
 
Female wild-type and OPN
 
2
 
/
 
2
 
 mice in a 129/
S3XC57BL/6F2 background (12) derived from the original het-
erozygous crosses were maintained as separate colonies. 12-wk-
old female OPN
 
2
 
/
 
2
 
 and wild-type mice (48 mice in total), 18–23 g
in body weight, were used in the experiments and randomly as-
signed in equal numbers to loaded control and unloaded tail sus-
pension groups.
 
Tail Suspension Model.
 
For tail suspension, a tape was applied
to the surface of the tail to set a metal clip. The end of the clip
was fixed to an overhead bar and the height of the bar was ad-
justed to maintain the mice at an 
 
z
 
30
 
8 
 
headdown tilt with the
hindlimbs elevated above the floor of the cage. One-half of the
mice in the tail suspension group was subjected to tail suspension
for 2 wk and the other half for 4 wk (
 
n
 
 5 
 
6 per group). Loaded
control mice were also housed individually under the same con-
dition except for tail suspension for the same duration (2 or 4
wk). The mice were injected intraperitoneally with calcein at 4
mg/kg 4 and 2 d before killing at 2 wk. After 2 or 4 wk of tail
suspension, mice were anesthetized with pentobarbital and were
killed by cervical dislocation.
 
Body Weight.
 
Body weights of either loaded or tail-sus-
pended mice, measured every day, were not altered during the 2-
and 4-wk experiments in both genotypes (data not shown). This
confirms that stress can be considered minimal in our experi-
ments, as previously concluded (22, 23).
 
Analysis of Bone Length.
 
The lengths of the femora and tibiae
measured on x-ray film were not altered in tail-suspended animals
compared with the loaded control in both genotypes after 4 wk
of tail suspension (data not shown).
 
m
 
-CT Analysis of Bone.
 
For measurements of the bone vol-
ume (BV/tissue volume [TV]), the bones were subjected to mi-
cro-x-ray computed tomography (
 
m
 
-CT) analysis, using Musashi
 
(Nittetsu-ELEX). The data were subsequently quantified by us-
ing a Luzex-F automated image analysis system (Nireco). The
fractional bone volume (BV/TV) was measured in the area of
0.39 mm
 
2
 
 with its closest and furthest edges at 0.34- and 0.62-
mm distal to the growth plate of the proximal ends of the tibiae.
Threshold for the measurements was set at 110 for the analyses.
 
Deoxypyridinoline Measurement.
 
Urinary deoxypyridinoline
(Dpyd) levels on day 14 of the tail suspension were measured by
ELISA (Metra Biosystems; reference 24). Urine collected from
two mice in a metabolic cage during the last 24 h (on day 14 of
tail suspension) was combined and three independent samples
from each group were analyzed.
 
Histomorphometric Analysis of Bone.
 
For decalcified sections
(left tibiae), serial 5-
 
m
 
m-thick sagittal sections were made using a
microtome and stained for tartrate-resistant acid phosphatase
(TRAP) followed by staining with toluidine blue. TRAP-posi-
tive multinucleated cells attached to bone were scored as osteo-
clasts. Measurements were made within an area of 0.32 mm
 
2
 
 with
its closest and furthest edges at 0.35- and 0.60-mm distal to the
growth plate of the proximal ends of the tibiae. Histomorphome-
try was conducted to quantify the number of osteoclasts (N.Oc/
BS) and osteoclast surface (Oc.S/BS) as defined by Parfitt et al.
(25).
For undecalcified sections (right tibiae), serial 3-
 
m
 
m-thick
frontal sections were made using a microtome. The metaphyseal
cancellous bone fraction was measured in an area with its closest
and furthest edges at 0.35- and 0.60-mm distal to the growth
plate. All the histomorphometric analyses were conducted within
this area.
 
Statistical Evaluations.
 
The results are presented as mean val-
ues 
 
6
 
 SEM. Statistical analysis was performed by Mann-Whit-
ney’s U test. A
 
 P 
 
value 
 
, 
 
0.05 was considered to be statistically
significant.
 
Results
 
Unloading Does Not Reduce Bone in OPN-deficient Mice.
 
In wild-type mice, trabecular bones in the midsagittal plane
of the metaphyseas in the tibiae observed in 
 
m
 
-CT analysis
became sparse due to unloading as expected (Fig. 1 A). In
contrast to wild-type, no deficiency in trabecular bone pat-
tern was observed in OPN
 
2
 
/
 
2
 
 mice even after tail suspen-
sion (Fig. 1 A). Quantification of the fractional trabecular
bone volume (BV/TV) in the 
 
m
 
-CT analysis indicated
 
z
 
50% reduction in wild-type after tail suspension (Fig. 1
B,
 
 P 
 
,
 
0.05), but in OPN
 
2
 
/
 
2
 
 mice no significant decrease
was observed (Fig. 1 B). The absence of the tail suspen-
sion–induced bone loss in OPN
 
2
 
/
 
2
 
 mice was similarly ob-
served at 2 wk of tail suspension (data not shown) com-
pared with 4 wk (Fig. 1, A and B). The basal levels of bone
volume fraction of the cancellous bones in OPN
 
2
 
/
 
2
 
 mice
were not different from those in wild-type (Fig. 1 B).
 
OPN Prevents the Unloading-induced Increase in the Levels of
Urinary Dpyd.
 
As an alternative method to evaluate bone
metabolism in OPN
 
2
 
/
 
2
 
 mice, we have evaluated a sys-
temic biochemical marker of bone resorption. Dpyd ap-
pearance in urine as a by-product of collagen degradation is
a biochemical marker of bone resorption that reflects sys-
temic bone resorption (24). Dpyd excretion on day 14 of
the tail suspension was increased about twofold compared 
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with the loaded group in wild-type animals as expected
(Fig. 2; 
 
P
 
 , 
 
0.05). In contrast, no significant increase was
observed in the tail-suspended OPN
 
2
 
/
 
2
 
 mice compared
with loaded OPN
 
2
 
/
 
2
 
 mice (Fig. 2). The basal levels of
Dpyd in loaded OPN
 
2
 
/
 
2
 
 mice were not different from
those in loaded wild-type mice. These results indicate that
in the absence of OPN there was no increase in the levels
of a systemic bone resorption marker from unloading.
 
OPN Is Required for the Unloading-induced Increase in the
Osteoclast Number.
 
To obtain insights into the cellular ba-
sis for the mechanism of OPN action on unloading-
induced bone loss, we examined osteoclasts and osteoblasts
histologically in the bones. In contrast to the unloading-
induced increase in the osteoclast number (N.Oc/BS) by
 
z
 
150% (
 
P 
 
, 
 
0.05; Fig. 3 A) and the osteoclast surface
(Oc.S/BS) by 
 
z
 
90% (
 
P 
 
, 
 
0.05; Fig. 3 B) in the proximal
ends of the tibiae after 2 wk in wild-type (Fig. 3 C), no dif-
 
ference in N.Oc/BS and Oc.S/BS was observed in un-
loaded OPN
 
2
 
/
 
2
 
 mice compared with loaded OPN
 
2
 
/
 
2
 
mice (Fig. 3, A and B). After 4 wk, the N.Oc/BS and
Oc.S/BS became similar between the tail-suspended and
control loaded mice in wild-type animals as reported previ-
ously, whereas again no difference was observed in OPN
 
2
 
/
 
2
 
mice (data not shown). These observations indicate that
OPN is required for the increase in the osteoclast number
caused by unloading.
We have gone on to ask whether the failure of the os-
teoclast number to increase after unloading is intrinsic to
osteoclastogenesis in the bone marrow cells in OPN
 
2
 
/
 
2
 
mice. Bone marrow cells obtained from the femora of un-
loaded and loaded mice were cultured in the presence of
soluble receptor activator of nuclear factor-
 
k
 
B ligand
(RANKL) and M-CSF (macrophage-CSF) for 9 d. The ef-
ficiency of the formation of TRAP-positive multinucleated
cells in these cultures was similar regardless of unloading or
loading in either wild-type or OPN
 
2
 
/
 
2
 
 mice (data not
shown). These results suggest that OPN deficiency does
not affect the proportions of bone marrow cells able to dif-
ferentiate into osteoclasts in vitro, at least under these con-
ditions.
 
OPN Is Required for the Unloading-induced Reduction in Os-
teoblastic Activity In Vivo.
 
Bone loss occurs as the result of
an imbalance between bone resorption and bone forma-
tion. This imbalance could result from a relative increase of
osteoclastic activity and/or a relative decrease in osteoblas-
tic activity. Therefore, in addition to the analyses on osteo-
clastic aspects, we also examined the effects of OPN defi-
ciency on unloading-induced bone loss with respect to
osteoblastic features by using calcein double labeling. In
loaded mice, basal levels of bone formation rate (BFR) and
mineral apposition rate (MAR) were similar regardless of
the genotypes (Fig. 4, A and B) based on the analyses of
calcein labeling (Fig. 4 C). In contrast to the reduction in
BFR and MAR in wild-type mice after unloading (
 
z
 
50
and 30%, respectively, 
 
P 
 
, 
 
0.05; Fig. 4, A and B), no alter-
ation in BFR and MAR was observed in OPN
 
2
 
/
 
2
 
 mice af-
ter unloading (Fig. 4, A and B).
Figure 1. m-CT tomographs and trabecular BV/TV of the tibiae of
loaded and unloaded mice. (A) m-CT pictures of the midsagittal planes of
the proximal regions of the tibiae after 4 wk of tail suspension (Susp) or
loading (Load) in wild-type or OPN2/2 mice. m-CT analyses were con-
ducted as described in Materials and Methods. (B) Fractional trabecular
BV/TV was quantified based on the image analysis of m-CT pictures of
the tibiae after 4 wk of either tail suspension (Susp) or loading (Load) in
wild-type or OPN2/2 mice shown in A. Analyses were conducted in the
rectangular 280 3 1,400 mm area of 340–620 mm distal to the growth
plate of the proximal ends of the tibiae. Each of the four groups consisted
of six mice. Data are expressed as means and standard errors. *Statistically
significant difference from respective control (P , 0.05).
Figure 2. Urinary Dpyd levels of loaded and unloaded mice. Urine of
either tail suspension (Susp) or loading (Load) from both wild-type or
OPN2/2 mice was collected during the last 24 h (on day 14). Urine from
two mice was combined and three independent samples per group were
analyzed by ELISA. Data are expressed as means and standard errors. *Sta-
tistically significant difference from respective control (P , 0.05). 
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Discussion
 
In this study, we demonstrated that OPN is required for
the unloading-induced enhancement of osteoclastic bone
resorption as well as the unloading-induced suppression of
osteoblastic bone formation, two major cellular events that
lead to bone loss. As a consequence, 
 
m
 
-CT examinations
revealed preservation of trabecular patterns and fractional
BV/TV in OPN
 
2
 
/
 
2 mice even after unloading. Moreover,
evaluation of the systemic biochemical parameters using
urinary Dpyd further confirmed that OPN deficiency pro-
tects bone against enhanced bone resorption in tail-sus-
pended mice. These observations clearly indicate that OPN
plays a critical role in the regulation of events that cause
unloading-induced bone loss.
The suppression of the increase in the osteoclast number
and osteoclast surface in OPN2/2 mice after unloading was
unexpected. It does not appear to be due to an intrinsic
deficit of osteoclastogenesis in OPN2/2 cells, at least in
vitro, since the bone marrow cells recovered from tail-sus-
pended OPN2/2 mice exhibited osteoclastogenesis at a
similar efficiency to the cells from tail-suspended wild-type
mice in vitro, in the presence of soluble RANKL and
M-CSF. Therefore, in the case of unloading-induced bone
Figure 3. An unloading-induced increase in the N.Oc/BS does not
occur in OPN2/2 mice. (A and B) In the decalcified sections at the ends
of the tibiae, the N.Oc/BS (A) and the Oc.S/BS (B) were measured
within an area of 350–600 mm distal to the growth plate. The N.Oc/BS
was calculated as the number of osteoclasts per bone surface, and the
Oc.S/BS was calculated as the percentage of bone surface covered by os-
teoclast per total bone surface. Data are expressed as means and standard
errors for six bones from each of the wild-type and OPN2/2 mice. *Sta-
tistically significant difference from respective control (P , 0.05). (C) Os-
teoclasts on the cancellous bones in the decalcified 5-mm-thick midsagit-
tal sections of the ends of the tibiae after tail suspension (Susp) or loading
(Load) in wild-type or OPN2/2 mice. TRAP-positive multinucleated
cells (red cells) attached to cancerous bone were counted as osteoclasts to
obtain data shown in A and B.
Figure 4. An unloading-induced reduction in osteoblastic activity in
vivo does not occur in OPN2/2 mice. (A and B) In the undecalcified sec-
tions of the proximal ends of the tibiae, (A) BFR and (B) MAR at 350–
600 mm distal to the growth plate in the metaphyseal region was mea-
sured as described in Materials and Methods. The mice were injected
intraperitoneally with calcein at 4 mg/kg 4 and 2 d before killing at 2 wk.
Data are expressed as means and standard errors for six bones from each of
the wild-type and OPN2/2 mice groups. *Statistically significant differ-
ence from respective control (P , 0.05). (C) Calcein double-labeled sur-
faces of the bones at the ends of the tibiae after tail suspension (Susp) or
loading (Load) in wild-type or OPN2/2 mice. Arrows indicate the lines
of calcein labeling (light green) used to obtain data shown in A and B.403 Ishijima et al. Brief Definitive Report
resorption, OPN may be involved in the mechanisms sens-
ing the physical force that induces the increase in the num-
ber of osteoclasts rather than osteoclastogenesis per se.
Although hindlimb suspension has been widely used as a
model of unloading, whether it enhances bone resorption
in the rodent, such as rat, bone is still a matter of dispute
(26). Our data clearly indicated an increase in bone resorp-
tion in the hindlimbs of the wild-type mice. The difference
in the efficiencies in osteoclastogenesis from OPN-null
cells in this and our previous paper (12) could be due to the
culture conditions, including the types of stimulators used
for the osteoclast development.
It is known that mechanical stress induces OPN produc-
tion, and this phenomenon has been suggested to trigger
events in mechanical stress–dependent bone formation and
bone resorption. However, no evidence has been obtained
to show that OPN really plays a role in vivo. Our data in
this paper indicate for the first time that the presence of
OPN is critical in mediating the effect of physical force to
change the metabolism of bone. With regard to unloading-
induced bone resorption, OPN could be required to mod-
ulate the development or recruitment of osteoclast precur-
sors upon unloading to augment the number of osteoclasts
and promote bone resorption, even though not required
for base line of osteoclastogenesis. OPN could act as a
chemoattractant as observed in other types of cells (27).
Thus, the role of OPN would be to provide critical regula-
tory information for the recruitment and/or development
of osteoclasts in a situation of acute bone resorption in
vivo. In this sense, OPN appears to be the bone resorp-
tion–inducing mechanical stress sensor that contributes to
unloading-induced bone resorption. Alternatively, OPN
functions downstream of the sensor and modulates cell
function as a consequence of signals generated by this sen-
sor in response to mechanical forces.
Our data also indicate that OPN is required to convey
the effect of mechanical stress to osteoblasts as shown by
the absence of a reduction of BFR and MAR in OPN2/2
mice subjected to tail suspension. This effect on bone for-
mation parameters might be secondary to the lack of in-
crease in the number of osteoclasts in unloaded OPN2/2
bones, and hence might be regarded as an indirect phe-
nomenon. However, this possibility is contradicted by the
fact that reduction in bone formation parameters has been
observed in tail-suspended animals even when bone re-
sorption was completely blocked by the treatment of ani-
mals with bisphosphonates (28, 29). Therefore, we con-
clude that OPN directly modulates bone formation in
response to mechanical stress independent of its effect on
osteoclasts. Although OPN-null mice may compensate for
weight deprivation in 2 wk, the fact that no alteration in
BFR was observed at a 2-wk time point suggests that this
possibility is less likely. The fact that OPN2/2 mice de-
velop normal skeletal structures and do not exhibit major
morphological defects (12) indicates that OPN is not re-
quired as a basic component for bone formation. Thus, the
observations on bone formation presented in this paper
highlight the point that OPN is a molecule which is re-
quired specifically to convey loss of mechanical stress–
dependent events to osteoblasts to negatively modulate ba-
sic bone-producing functions.
The basal levels of bone volume fraction of the cancel-
lous bones and osteoclast number in the 14-wk-old
OPN2/2 mice used in this paper were not different from
those in wild-type. This could be due to the age depen-
dence of the phenotype as described in previous papers (12,
15), where mild osteopetrosis was observed in older (25 6
3-wk-old) OPN-null mice (15) but not in the younger
mice. We assume that age-dependent suppression of osteo-
clastic activity could result in mild osteopetrosis and a mild
hypocalcemic state which may stimulate osteoclastogenesis
in the older null mice for compensation. Age may have also
affected in vitro osteoclastogenesis. Age dependence of os-
teopetrosis was similarly described in b3-integrin knockout
mice (30).
Taken together, our data provide evidence that OPN is
required for both the increase in osteoclasts to enhance
bone resorption and the decrease in osteoblastic function to
suppress bone formation, two cellular phenomena in bone
that are well characterized in tail-suspended mice. There-
fore, OPN plays a key role in conveying the effect of me-
chanical stress to these two types of bone cells, major regu-
lators that determine bone mass in response to mechanical
stress.
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